Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Diageo (DGE) by Alan Oscroft in The Motley Fool
- Buy St James's Place (STJ) by Alan Oscroft in The Motley Fool
- Neutral Lonmin (LMI) by Goldman Sachs
- Buy Codemasters Group Holdings (CDM) by Berenberg
- Buy Frontier Developments (FDEV) by Berenberg
- Buy Barclays (BARC) by Berenberg
- Buy Sumo Group (SUMO) by Berenberg
- Neutral Petra Diamonds Ltd.(DI) (PDL) by Goldman Sachs
- Hold Mcbride (MCB) by Berenberg
- Hold Greene King (GNK) by HSBC
- Buy Wetherspoon (J.D.) (JDW) by HSBC
- Hold Intu Properties (INTU) by Berenberg
- Outperform Gocompare.com Group (GOCO) by RBC Capital
- Neutral Centamin (DI) (CEY) by Goldman Sachs
- Conviction Buy Fresnillo (FRES) by Goldman Sachs
- Hold Anglo American (AAL) by Barclays
- Neutral Centrica (CNA) by Goldman Sachs
- Sector Perform SEGRO (SGRO) by RBC Capital
- Outperform BAE Systems (BA.) by Credit Suisse
- Neutral HSBC Holdings (HSBA) by Credit Suisse
Oxford Biomedica (OXB)
Health Care Sector
-
Latest quote
640.00p (mid)
-
Current Change (%)
1.57%
-
Price
Bid: 639.90p
Offer: 640.00p
-
Today
High: 655.80p
Low: 630.00p
-
This year
High: 1,050.00p
Low: 526.00p
-
Information
Volume: 24,114
Market Cap: £422.4M
Oxford Biomedica RNS Feed
| Title | Release date |
|---|---|
| Notice of Results | 07:00 - February 8, 2019 |
| Director/PDMR Shareholding | 11:49 - February 7, 2019 |
| Update on programmes outlicensed to Sanofi | 09:22 - February 7, 2019 |
| Director Dealings / Market Share Transactions | 11:00 - February 6, 2019 |
| Director Dealings / Market Share Purchase | 10:22 - February 5, 2019 |
| Total Voting Rights | 10:00 - February 1, 2019 |
| Director Dealings / Market Share Purchase | 11:20 - January 24, 2019 |
| Director Dealings / Market Share Purchase | 10:51 - January 18, 2019 |
| Block listing Interim Review | 12:20 - January 3, 2019 |
| Total Voting Rights | 10:17 - January 2, 2019 |
| Director Dealings / Market Share Purchase | 13:16 - December 21, 2018 |
| Axovant FDA meeting feedback | 16:11 - December 6, 2018 |
| Total Voting Rights | 09:53 - December 3, 2018 |
| Longer term Kymriah efficacy and safety data | 07:00 - December 3, 2018 |
| Director Dealings | 10:41 - November 23, 2018 |
NOTE: This is based on 27 open tips for this company
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000
